118 related articles for article (PubMed ID: 9587048)
1. Comparative bioavailability of various thiamine derivatives after oral administration.
Greb A; Bitsch R
Int J Clin Pharmacol Ther; 1998 Apr; 36(4):216-21. PubMed ID: 9587048
[TBL] [Abstract][Full Text] [Related]
2. Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD).
Frank T; Bitsch R; Maiwald J; Stein G
Int J Clin Pharmacol Ther; 1999 Sep; 37(9):449-55. PubMed ID: 10507244
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of thiamine derivatives especially of benfotiamine.
Loew D
Int J Clin Pharmacol Ther; 1996 Feb; 34(2):47-50. PubMed ID: 8929745
[TBL] [Abstract][Full Text] [Related]
4. Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations.
Park WS; Lee J; Hong T; Park G; Youn S; Seo Y; Lee S; Han S
Clin Ther; 2016 Oct; 38(10):2277-2285. PubMed ID: 27707509
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and bioequivalence evaluation of 2 levosulpiride preparations after a single oral dose in healthy male Korean volunteers.
Cho HY; Moon JD; Lee YB
Int J Clin Pharmacol Ther; 2004 Mar; 42(3):174-80. PubMed ID: 15049438
[TBL] [Abstract][Full Text] [Related]
6. High thiamine diphosphate concentrations in erythrocytes can be achieved in dialysis patients by oral administration of benfontiamine.
Frank T; Bitsch R; Maiwald J; Stein G
Eur J Clin Pharmacol; 2000 Jun; 56(3):251-7. PubMed ID: 10952481
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability assessment of the lipophilic benfotiamine as compared to a water-soluble thiamin derivative.
Bitsch R; Wolf M; Möller J; Heuzeroth L; Grüneklee D
Ann Nutr Metab; 1991; 35(5):292-6. PubMed ID: 1776825
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system.
Liu ZX; Artmann C
Altern Ther Health Med; 2009; 15(2):42-6. PubMed ID: 19284181
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
12. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: an open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteers.
Rhim SY; Park JH; Park YS; Lee MH; Kim DS; Shaw LM; Yang SC; Kang JS
Clin Ther; 2009 May; 31(5):1037-45. PubMed ID: 19539104
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride.
Xie F; Cheng Z; Li S; Liu X; Guo X; Yu P; Gu Z
J Clin Pharmacol; 2014 Jun; 54(6):688-95. PubMed ID: 24399744
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and bioequivalence testing of generic ondansetron preparations in healthy Thai male volunteers.
Rojanasthien N; Manorot M; Kumsorn B
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):548-54. PubMed ID: 10584976
[TBL] [Abstract][Full Text] [Related]
17. New metabolic and pharmacokinetic characteristics of thiocolchicoside and its active metabolite in healthy humans.
Trellu M; Filali-Ansary A; Françon D; Adam R; Lluel P; Dubruc C; Thénot JP
Fundam Clin Pharmacol; 2004 Aug; 18(4):493-501. PubMed ID: 15312157
[TBL] [Abstract][Full Text] [Related]
18. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrate.
Schreeb KH; Freudenthaler S; Vormfelde SV; Gundert-Remy U; Gleiter CH
Eur J Clin Pharmacol; 1997; 52(4):319-20. PubMed ID: 9248773
[No Abstract] [Full Text] [Related]
20. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
